Chan B P, Yuen W F, Lee W H, Wong S N, Chung T Y, Wu Y J, Pang S F
The University of Hong Kong, Hong Kong Special Administrative Region, China.
Immunopharmacol Immunotoxicol. 2004 May;26(2):177-92. doi: 10.1081/iph-120037713.
The current study investigated the immunomodulating effect of CKBM on cytokine induction in peripheral blood mononuclear cells (PBMCs) isolated from 20 healthy volunteers. Cytometric Bead Analysis (CBA) was used to study IL-2, IL-4, IL-6, IL-10, TNF-alpha and IFN-gamma. TNF-alpha and IL-6 were significantly increased in a CKBM dose- and time-dependent manner. Flow cytometry analysis showed an increased intracellular staining of IL-6 but not of TNF-alpha in CKBM treated PBMCs. In addition, MTT cell cytotoxicity assay showed that CKBM concentrations below 5% did not significantly affect the metabolic activities of PBMCs. The current study indicated that CKBM may modulate the immune response by inducing the secretions of TNF-alpha and IL-6, which are cytokine mediators of innate immunity and inflammation preparing or "priming" the body to combat diseases.
本研究调查了CKBM对从20名健康志愿者分离的外周血单个核细胞(PBMC)中细胞因子诱导的免疫调节作用。采用细胞计数微珠分析(CBA)研究白细胞介素-2(IL-2)、白细胞介素-4(IL-4)、白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)和干扰素-γ(IFN-γ)。TNF-α和IL-6以CKBM剂量和时间依赖性方式显著增加。流式细胞术分析显示,在经CKBM处理的PBMC中,IL-6的细胞内染色增加,但TNF-α没有增加。此外,MTT细胞毒性试验表明,浓度低于5%的CKBM对PBMC的代谢活性没有显著影响。本研究表明,CKBM可能通过诱导TNF-α和IL-6的分泌来调节免疫反应,TNF-α和IL-6是先天免疫和炎症的细胞因子介质,可使机体做好准备或“启动”以对抗疾病。